XML 89 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Share-based awards (Tables)
12 Months Ended
Mar. 31, 2019
Share-based awards  
Schedule of share-based compensation expense by function

 

 

 

 

 

 

 

 

 

Year ended March 31, 

 

    

2017

    

2018

    

2019

 

 

(in millions of RMB)

Cost of revenue

 

3,893

 

5,505

 

8,915

Product development expenses

 

5,712

 

7,374

 

15,378

Sales and marketing expenses

 

1,772

 

2,037

 

4,411

General and administrative expenses

 

4,618

 

5,159

 

8,787

Total

 

15,995

 

20,075

 

37,491

 

RSUs  
Share-based awards  
Summary of changes in the RSUs

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

average

 

 

 

 

grant date

 

 

Number

 

fair value

 

    

of  RSUs

    

per RSU

 

 

 

 

US$

Awarded and unvested as of April 1, 2018

 

68,424,858

 

100.93

Granted

 

24,863,988

 

181.74

Vested

 

(24,337,392)

 

84.31

Cancelled/forfeited

 

(4,604,961)

 

135.06

Awarded and unvested as of March 31, 2019

 

64,346,493

 

136.00

Expected to vest as of March 31, 2019 (i)

 

53,175,748

 

134.59

 

(i)RSUs expected to vest are the result of applying the pre-vesting forfeiture rate assumptions to total outstanding RSUs.

Options  
Share-based awards  
Summary of changes in the share options

 

 

 

 

 

 

 

 

 

    

 

    

 

    

 

 

 

 

 

Weighted

 

 

 

 

 

 

average

 

Weighted

 

 

 

 

exercise

 

average

 

    

Number

    

price

    

remaining

 

 

of share

 

per share

 

contractual

 

 

options

 

option

 

life

 

 

 

 

US$

 

(in years)

Outstanding as of April 1, 2018

 

7,938,015

 

70.10

 

4.5

Exercised

 

(795,809)

 

45.02

 

 

Cancelled/forfeited/expired

 

(25,000)

 

76.81

 

 

Outstanding as of March 31, 2019

 

7,117,206

 

72.88

 

3.7

Vested and exercisable as of March 31, 2019

 

3,258,039

 

75.32

 

3.6

Vested and expected to vest as of March 31, 2019 (i)

 

7,016,598

 

72.78

 

3.7

 

(i)

Share options expected to vest are the result of applying the pre-vesting forfeiture rate assumptions to total outstanding share options.

Schedule of fair value assumptions

 

 

 

 

 

 

Year ended March 31,

 

    

2017

Risk-free interest rate (i)

 

1.23% – 1.30%

Expected dividend yield (ii)

 

0%

Expected life (years) (iii)

 

4.38

Expected volatility (iv)

 

31.7% – 33.2%

 

(i)

Risk-free interest rate is based on the yields of United States Treasury securities with maturities similar to the expected life of the share options in effect at the time of grant.

(ii)

Expected dividend yield is assumed to be nil as the Company has no history or expectation of paying a dividend on its ordinary shares.

(iii)

Expected life of share options is based on the average between the vesting period and the contractual term for each grant.

(iv)

Expected volatility is assumed based on the historical volatility of the Company’s comparable companies in the period equal to the expected life of each grant.

Partner Capital Investment Plan | Subscription rights  
Share-based awards  
Schedule of fair value assumptions

 

 

 

 

 

 

 

 

 

 

 

 

Year ended March 31,

 

 

    

2017

    

2018

 

2019

 

Risk-free interest rate (i)

 

1.86

%  

2.07

%  

2.94

%

Expected dividend yield (ii)

 

 0

%  

 0

%  

 0

%

Expected life (years) (iii)

 

8.25

 

8.25

 

8.25

 

Expected volatility (iv)

 

39.0

%  

34.2

%  

33.0

%

 

(i)

Risk-free interest rate is based on the yields of United States Treasury securities with maturities similar to the expected life of the share-based awards in effect at the time of grant.

(ii)

Expected dividend yield is assumed to be nil as the Company has no history or expectation of paying a dividend on its ordinary shares.

(iii)

Expected life of the rights is based on management’s estimate on timing of redemption for ordinary shares by the participants.

(iv)

Expected volatility is assumed based on the historical volatility of the Company’s comparable companies in the period equal to expected life of each right.